Cat. No. | Product Description | Size&Price | Compare |
PPM-M1001 | Star Ribbon Pre-stained Protein Marker (8-180kDa) | ||
PPM-M1003 | Star Ribbon Pre-stained Protein Marker (40-275 kDa) | ||
PPM-M1002 | Star Ribbon Pre-stained Protein Marker (2.7-40 kDa) |
Molecule | Cat. No. | Species | Product Description | Host | Structure | Purity | Feature | Size&Price | Compare |
VLP | VLP-NF2P4 | - | Fluorescent Virus-Like Particle (VLP) Protein Isotype Control | HEK293 | |||||
VLP | VLP-N5213 | - | Virus-Like Particle (VLP) Protein Isotype Control | HEK293 | |||||
Nuclease |
BEE-N3116
DMF
|
- | GENIUS™Nuclease | E. coli |
|
Cat. No. | Product Description | Size&Price | Compare |
RES-A004 | resDetect™ Kanamycin ELISA Kit | ||
RES-A025 | resDetect™ Gentamicin ELISA Kit |
Cat. No. | Product Description | Size&Price | Compare |
MBS-K013 | Human ACE2-coupled Magnetic Beads | ||
MBS-K014 | Human Anti-SARS-CoV-2 Spike RBD Antibody-coupled Magnetic Beads |
Cat. No. | Product Description | Size&Price | Compare |
FCM-C03M | Magnetic Capture Plate |
Cat. No. | Product Description | Size&Price | Compare |
FCM-B01M | 96-Well Filter Plate | ||
SP-11 | Streptavidin Coated Plates, Clear, 12×8-Well Strips, White Frame |
Cat. No. | Product Description | Size&Price | Compare |
DB-02 | Dilution Buffer (Strengthen Blocking) | ||
DC-11 | 200x DDM CHS buffer | ||
ABK-001 | Chemiluminescent Substrate Solution (AE Marker) | ||
ABK-002 | Chemiluminescent Substrate Solution (HRP Marker) |
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
Antagonizing TSP1/CD36 Polypeptide Blocking the activation of TGF-β1 | Fusion/Recombination protein | Respiratory disease | IPF,PF-ILD | IND | Global (except China) |
ActRIIB inhibitor | Small molecule | Oncology/Cancer | Cancer cachexia | Preclinical | Global |
PEGylation CD3 + CD19 bsAb | Monospecific antibody | Immunological disease | Immunodeficiencies | IND | Global |
CD19 mAb | Monospecific antibody | Immunological disease | autoimmune disease | IND | Global |
Orexin Receptor Antagonist (OX1R and OX2R) | Small molecule | Neurological disease | Insomnia Disorder | Phase III | Global (except China) |
CD37+CD22 CAR-T | Cell therapy | Oncology/Cancer | AML | PCC | Global |
CD40 mAb | Monospecific antibody | Oncology/Cancer | Advanced solid tumor | Phase I | Global |
CD47 Monoclonal Antibody | Monospecific antibody | Oncology/Cancer | Advanced solid tumor,Advanced hematological tumor | IND | Global |
c-Met/AXL inhibitor | Small molecule | Oncology/Cancer | Gastric cancer | Phase I | Global |
EGFR inhibitor | Small molecule | Oncology/Cancer | Esophageal Carcinoma Pancreatic Cancer | Phase III | Global |
FRα BsAb-ADC | Bispecific antibody | Oncology/Cancer | Ovarian cancer | Preclinical | Global |
Her2xCD3 BsAb | Bispecific antibody | Oncology/Cancer | HER2-positive Cancer | Phase I | Global |
This web search service is supported by Google Inc.